Table 6.
Number of transfusions before first AE | Per-patient basis |
---|---|
Total patient population (n = 4067, 126 AE) | |
1 | 37 (0·91%) |
2 | 16 (0·39%) |
3 | 8 (0·20%) |
4 | 9 (0·22%) |
5 | 5 (0·12%) |
6–10 | 22 (0·54%) |
11–19 | 15 (0·37%) |
≥20 | 14 (0·34%) |
Mean (SD) | 8·3 (14·6) |
Median | 4 |
Minimum–Maximum | 1–139 |
Paediatric patients (n = 242, 13 AE) | |
1 | 3 (1·24%) |
2 | 1 (0·41%) |
4 | 1 (0·41%) |
6–10 | 4 (1·65%) |
11–19 | 2 (0·83%) |
≥20 | 2 (0·83%) |
Mean (SD) | 9·8 (10·1) |
Median | 6 |
Minimum–Maximum | 1–30 |
Haematology–Oncology patients (n = 2038, 111 AE) | |
1 | 26 (1·28%) |
2 | 14 (0·69%) |
3 | 8 (0·39%) |
4 | 9 (0·44%) |
5 | 5 (0·25%) |
6–10 | 20 (0·98%) |
11–19 | 15 (0·74%) |
≥20 | 14 (0·69%) |
Mean (SD) | 9·2 (15·3) |
Median | 4 |
Minimum–Maximum | 1–139 |
Cardiovascular patients (n = 593, 3 AE) | |
1 | 2 (0·34%) |
6–10 | 1 (0·17%) |
Mean (SD) | 2·7 (2·9) |
Median | 1 |
Minimum–Maximum | 1–6 |
AE, adverse event.